Companies Dominating the Microbial Fermentation Technology Landscape
- Biocon Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BioVectra Inc.
- Danone UK
- F. Hoffmann-La Roche AG
- Koninklijke DSM NV
- Lonza
- Novozymes A/S
- TerraVia Holdings, Inc.
- BIOZEEN
- Royal DSM
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of microbial fermentation technology is assessed at USD 36.57 billion.
The microbial fermentation technology market size was valued at USD 34.92 billion in 2024 and is set to reach USD 73.57 billion by the end of 2037, registering around 5.9% CAGR during the forecast period i.e., between 2025-2037. The rising need for vaccines and the growing need for microbial contract manufacturing services will drive the market growth.
Asia Pacific industry is set to dominate majority revenue share 42% by 2037, impelled by presence of the developed chemical sector in the region.
The major players in the market are BioVectra Inc., Danone UK, F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN
